ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

PHIO Phio Pharmaceuticals Corporation

0.88
0.1043 (13.45%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Phio Pharmaceuticals Corporation PHIO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.1043 13.45% 0.88 18:59:58
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.81 0.7762 0.8299 0.8197 0.7757
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202406:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
22/4/202412:10GLOBEIntratumoral Injection of Phio’s PH-762 significantly..
16/4/202406:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentations at the..
11/4/202406:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
03/4/202406:30GLOBENational Spotlight Features Phio’s Innovative RNAi..
02/4/202406:30GLOBEPhio Pharmaceuticals Reports 2023 Year End Financial Results..
21/3/202406:30GLOBEPhio Pharmaceuticals Presenting Data Showing INTASYL May..
13/3/202413:00GLOBEPhio Pharmaceuticals Announces Addition of Clinical Trial..
06/3/202409:30GLOBEPhio Pharmaceuticals Announces Patent Granted by USPTO,..
05/3/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202409:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202407:00GLOBEPhio Pharmaceuticals Announces Data Showing INTASYL May..
26/1/202416:00EDGAR2Form 8-K - Current report
28/12/202308:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202315:52EDGAR2Form S-1 - General form for registration of securities under..
08/12/202316:00EDGAR2Form 8-K - Current report
07/12/202307:00GLOBEPhio Pharmaceuticals Announces Exercise of Warrants for $2.8..
09/11/202315:40EDGAR2Form 8-K - Current report
09/11/202315:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:30GLOBEPhio Pharmaceuticals Reports Third Quarter 2023 Financial..
09/11/202306:30GLOBEPhio Pharmaceuticals Announces First US Patient Enrolled in..
03/11/202311:00GLOBEPhio Pharmaceuticals Presents New Data Showing INTASYL..
12/10/202310:00GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
11/10/202306:30GLOBEPhio Pharmaceuticals Presents New Data for Targeting of BRD4..
06/9/202306:30GLOBEPhio CEO to Speak at Wainwright Conference in New York in..
21/8/202306:30GLOBEPhio Pharmaceuticals Announces Dosing of First Patient in..
21/8/202306:30EDGAR2Form 8-K - Current report
10/8/202315:40EDGAR2Form 8-K - Current report
10/8/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:30GLOBEPhio Pharmaceuticals Reports Second Quarter 2023 Financial..
26/7/202315:30EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock